Indications for cardiac resynchronization therapy: Should they be extended?

European Heart Journal, Supplement

Volumn 5, Issue I, 2003, Pages

  Rivero Ayerza, M ^a   De Backer, T ^a   Vanderheyden, M ^a   Geelen, P ^a   Goethals, M ^a   De Zutter, M ^a   Kalpakos, D ^a   Brugada, Pedro ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Cardiac resynchronization therapy; Chronic heart failure; ECG; Echocardiography; Left bundle branch block; Left ventricular remodelling

Indexed keywords

ACCURACY; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; ECHOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE REMODELING; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0345724919     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1520-765x(03)80015-9     Document Type: Conference Paper

References (31)

1. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133:703-12.
2. The CONSENSUS trial study group. Effects of enalapril in mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Eng J Med 1987;316:1429-35.
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
4. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
5. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
6. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709-17.
7. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-50
8. Toquero J, Geelen P, Goethals M, Brugada P. What is first, left bundle branch block or left ventricular dysfunction? J Cardiovasc Electrophysiol 2001;12:1425-28.
9. Bakker P, Meijburg H, de Jonge N, et al. Beneficial effects of biventricular pacing in congestive heart failure [abstract]. Pacing Clin Electrophysiol 1994;17:820.
10. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
11. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-53.
12. Bristow MR, et al. Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial. Presented in the 52nd American College of Cardiology Annual Scientific Sessions, 2003.
13. Erdogan A, Rueckleben S, Tillmanns H, Waldecker B. Proportion of candidates for cardiac resynchronization therapy. Pacing Clin Electrophysiol 2003;26:152-54.
14. Galizio NO, Pesce R, Valero E, et al. Which patients with congestive heart failure may benefit from binventricular pacing? Pacing Clin Electrophysiol 2003;26:158-61.
15. Wofram G, Sharkova J, Reinhard F, Maisch B. How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy? Pacing Clin Electrophysiol 2003;26:155-57.
16. Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957-65.
17. Penicka M, Bartunek J, De Bruyne B, et al. Tissue Doppler assessment of asynchrony predicts positive left ventricular remodeling after biventricular pacing in heart failure. Circulation 2002;106:3185.
18. Lunati M, Paolucci M, Oliva F, et al. Patient selection for biventricular pacing. J Cardiovasc Electrophysiol 2002;13 (suppl 1):S63-7.
19. Oguz E, Dagdeviren B, Bilsel T. Echocardiographic prediction of long-term response to biventricular pacemaker in severe heart failure. Eur J Heart Fail 2002;4:83-9.
20. Alonso C, Leclerq C, Victor F, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999;84:1417-21.
21. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003;91:684-88.
22. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the multisite stimulation in cardiomyopathy study. J Am Coll Cardiol 2002;40:111-8.
23. Ansalone G, Giannantoni P, Ricci R, et al. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 2002;39:489-99.
24. Gasparini M, Mantica M, Galimberti P, et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin Electrophysiol 2003;26:162-68.
25. Duncan A, Wait D, Gibson D, Daubert JC. Left ventricular remodeling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC trial. Eur Heart J 2003;24:430-41.
26. St John Sutton M, Plappert T, Abraham W, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107:1985-90.
27. Soogard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723-30.
28. St John Sutton M, Pfeffer MA, Plappert T, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: the protective effects of captopril. Circulation 1994;89:68-75.
29. Burns RJ, Gibbons FJ, Yi Q, et al. The relationship of left ventricular ejection fraction, end-systolic volume index and infract size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-6.
30. St John Sutton M, Pfeffer MA, Moye L, et al. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997; 96:3294-9.
31. Vasan RS, Larson MG, Benjamin EF, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997;336: 1350-5.